Is the extraction of third molars a risk factor for the temporomandibular disorders? A systematic review.

Oral surgery Risk Temporomandibular joint Temporomandibular joint disorders Temporomandibular joint dysfunction syndrome Third molar

Journal

Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 12 03 2020
accepted: 04 04 2020
pubmed: 11 8 2020
medline: 23 9 2020
entrez: 11 8 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate through a systematic review the extraction of third molars as a risk factor for temporomandibular disorders (TMDs). Randomized and nonrandomized controlled clinical trials where patients underwent third molar extraction and with qualitative evaluation of TMDs before and after extraction were included. After applying the inclusion criteria, seven nonrandomized clinical studies were included. QUIPS tool showed that four articles presented a moderate and three a high risk of bias (RoB). Six studies reported that TMDs presented higher level after removal of third molars ranging from OR, 1.81 to 2.15/RR, 2.1. However, one study showed no significant association. GRADE showed heterogeneity in relation to general results, which means that confidence in the estimated effects varied from low to moderate GRADE. The quality of clinical recommendations decreased especially due to the risk of bias in some of the included studies evaluated with the QUIPS tool. Third molar extraction can be associated with the development of TMD signs and symptoms. Furthermore, TMD can be aggravated according to the third molar location, the degree of impaction and surgical difficulty, age, and gender. This systematic review highlights the need to perform randomized clinical trials with diagnostic criteria and standardized surgical procedures.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to evaluate through a systematic review the extraction of third molars as a risk factor for temporomandibular disorders (TMDs).
TYPES OF STUDIES REVIEWED METHODS
Randomized and nonrandomized controlled clinical trials where patients underwent third molar extraction and with qualitative evaluation of TMDs before and after extraction were included.
RESULTS RESULTS
After applying the inclusion criteria, seven nonrandomized clinical studies were included. QUIPS tool showed that four articles presented a moderate and three a high risk of bias (RoB). Six studies reported that TMDs presented higher level after removal of third molars ranging from OR, 1.81 to 2.15/RR, 2.1. However, one study showed no significant association. GRADE showed heterogeneity in relation to general results, which means that confidence in the estimated effects varied from low to moderate GRADE. The quality of clinical recommendations decreased especially due to the risk of bias in some of the included studies evaluated with the QUIPS tool.
CONCLUSIONS AND PRACTICAL IMPLICATIONS CONCLUSIONS
Third molar extraction can be associated with the development of TMD signs and symptoms. Furthermore, TMD can be aggravated according to the third molar location, the degree of impaction and surgical difficulty, age, and gender. This systematic review highlights the need to perform randomized clinical trials with diagnostic criteria and standardized surgical procedures.

Identifiants

pubmed: 32776170
doi: 10.1007/s00784-020-03277-6
pii: 10.1007/s00784-020-03277-6
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Pagination

3325-3334

Auteurs

Yohana Sandy Souza Damasceno (YSS)

Department of Orthodontics, Dental School, Faculty of Dentistry, Federal University of Pará (UFPA), Augusto Correa St., no 1, Belém, Pará, 66075-110, Brazil.

Daybelis González Espinosa (DG)

Department of Orthodontics, Dental School, Faculty of Dentistry, Federal University of Pará (UFPA), Augusto Correa St., no 1, Belém, Pará, 66075-110, Brazil.
Facultad de Odontologi, Universidad Católica Redemptoris Mater, Managua, Nicaragua.

David Normando (D)

Department of Orthodontics, Dental School, Faculty of Dentistry, Federal University of Pará (UFPA), Augusto Correa St., no 1, Belém, Pará, 66075-110, Brazil. davidnormando@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH